Anton H. Stalenhoef

Nijmegen, GE 6525GA, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Cardiometabolic Differences in People Living with HIV Receiving Integrase Strand Transfer Inhibitors Compared to Non-nucleoside Reverse Transcriptase Inhibitors: Implications for Current ART Strategies.

Cardiometabolic Differences in People Living with HIV Receiving Integrase Strand Transfer Inhibitors Compared to Non-nucleoside Reverse Transcriptase Inhibitors: Implications for Current ART Strategies.

Journal: Viruses

Published: March 08, 2024

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

Journal: Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir

Published: March 01, 2015

Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.

Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.

Journal: European heart journal

Published: February 16, 2015

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society.

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society.

Journal: European heart journal

Published: July 24, 2014

Annexin A5 haplotypes in familial hypercholesterolemia: lack of association with carotid intima-media thickness and cardiovascular disease risk.

Annexin A5 haplotypes in familial hypercholesterolemia: lack of association with carotid intima-media thickness and cardiovascular disease risk.

Journal: Atherosclerosis

Published: June 08, 2014

Treatment options for hypertriglyceridemia: from risk reduction to pancreatitis.

Treatment options for hypertriglyceridemia: from risk reduction to pancreatitis.

Journal: Best practice & research. Clinical endocrinology & metabolism

Published: May 21, 2014

Familial combined hyperlipidemia: from molecular insights to tailored therapy.

Familial combined hyperlipidemia: from molecular insights to tailored therapy.

Journal: Current opinion in lipidology

Published: May 09, 2014

The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management.

The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management.

Journal: The lancet. Diabetes & endocrinology

Published: April 16, 2014

Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome.

Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome.

Journal: European heart journal

Published: March 04, 2014

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.

Journal: European heart journal

Published: August 20, 2013

Combining risk markers improves cardiovascular risk prediction in women.

Combining risk markers improves cardiovascular risk prediction in women.

Journal: Clinical science (London, England : 1979)

Published: July 25, 2013

Overexpression of angiopoietin-like protein 4 protects against atherosclerosis development.

Overexpression of angiopoietin-like protein 4 protects against atherosclerosis development.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: May 04, 2013

Showing 1-12 of 25

Last Updated: 09/26/2026